ArticleJournal of virology2003

T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

Nancy Dumais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.